Area of research
Infectious Diseases · Rheumatology
Research interest
Research focused on Antibody and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with related work in Coronavirus disease 2019 (COVID-19), Dyslipidemia, Malaria. Notable publications include 'Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study', 'Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study', and 'Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives'.
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study
Body mass index and response to infliximab in rheumatoid arthritis.
PubMed 2015cited by 51position: middle
Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe
Abstract 17096: Assessing the Prevalence of Atherogenic Dyslipidemia in EURIKA Patients
C-reactive protein levels in patients at cardiovascular risk: EURIKA study